Biological therapies, such as tocilizumab, adalimumab, etanercept, infliximab, abatacept, and TNF inhibitor, have been studied as alternative medicines to treat GCA, but their function and effectiveness remain uncertain.8 This evidence concerns the gene TNF and temporal arteritis.